Albert D Mason Inc Myriad Genetics Inc Transaction History

Albert D Mason Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 29, 2019	SELL	$27.23 - $45.56 $175,361 - $293,406	-6,440 Closed	0 $0
Q3 2018 Oct 30, 2018	SELL	$37.57 - $50.34 $53,725 - $71,986	-1,430 Reduced 18.17%	6,440 $296,000
Q2 2018 Jul 31, 2018	SELL	$27.75 - $40.17 $230,103 - $333,089	-8,292 Reduced 51.31%	7,870 $294,000
Q1 2018 May 02, 2018	SELL	$28.83 - $41.01 $7,784 - $11,072	-270 Reduced 1.64%	16,162 $478,000
Q4 2017 Feb 06, 2018	BUY	$28.45 - $37.14 $3,129 - $4,085	110 Added 0.67%	16,432 $564,000
Q3 2017 Oct 18, 2017	BUY	$24.01 - $36.2 $391,891 - $590,856	16,322	16,322 $591,000

232

92.6M

117K

113K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $2.21B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Albert D Mason Inc, based on Form 13F filings with the SEC.

Stay updated on Albert D Mason Inc with notifications on news.